Trials / Unknown
UnknownNCT04606212
The Effects of Losartan on Emotion Processing
Losartan Effects on the Emotion Processing in Humans
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 90 (estimated)
- Sponsor
- University of Electronic Science and Technology of China · Academic / Other
- Sex
- All
- Age
- 18 Years – 30 Years
- Healthy volunteers
- Accepted
Summary
The aim of the study is to investigate the effect of losartan (50mg, single dose) on salience processing
Detailed description
In a double-blind, between-subject, placebo-controlled design the effects of a single dose of losartan (50mg) on salience processing in healthy participants will be examined. The study will adopt a previously validated visual Oddball fMRI paradigm, starting 90 minutes after subjects receive 50mg losartan or placebo. The task requires participants to respond to emotional and novelty oddballs. Neural activity will be assessed by the acquisition of functional magnetic resonance imaging (fMRI) data.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Losartan | administration of losartan (50 mg) (oral) |
| DRUG | Placebo Oral Tablet | administration of placebo (oral) |
Timeline
- Start date
- 2020-10-10
- Primary completion
- 2021-12-31
- Completion
- 2022-03-31
- First posted
- 2020-10-28
- Last updated
- 2020-10-28
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04606212. Inclusion in this directory is not an endorsement.